Your browser doesn't support javascript.
loading
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma.
Rejeski, Kai; Perez, Ariel; Sesques, Pierre; Hoster, Eva; Berger, Carolina; Jentzsch, Liv; Mougiakakos, Dimitrios; Frölich, Lisa; Ackermann, Josephine; Bücklein, Veit; Blumenberg, Viktoria; Schmidt, Christian; Jallades, Laurent; Fehse, Boris; Faul, Christoph; Karschnia, Philipp; Weigert, Oliver; Dreyling, Martin; Locke, Frederick L; von Bergwelt-Baildon, Michael; Mackensen, Andreas; Bethge, Wolfgang; Ayuk, Francis; Bachy, Emmanuel; Salles, Gilles; Jain, Michael D; Subklewe, Marion.
Afiliação
  • Rejeski K; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Perez A; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.
  • Sesques P; German Cancer Consortium, Munich Site, and German Cancer Research Center, Heidelberg, Germany.
  • Hoster E; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
  • Berger C; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, Pierre-Bénite, France.
  • Jentzsch L; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Mougiakakos D; Institute for Medical Informatics, Biometry and Epidemiology, LMU Munich, Munich, Germany.
  • Frölich L; Department of Hematology, Oncology and Pulmonology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Ackermann J; Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Bücklein V; Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany; and.
  • Blumenberg V; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Schmidt C; German Cancer Consortium, Munich Site, and German Cancer Research Center, Heidelberg, Germany.
  • Jallades L; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Fehse B; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Faul C; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.
  • Karschnia P; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Weigert O; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany.
  • Dreyling M; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Locke FL; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, Pierre-Bénite, France.
  • von Bergwelt-Baildon M; Department of Hematology, Oncology and Pulmonology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Mackensen A; Department of Hematology, Oncology, Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Bethge W; German Cancer Consortium, Munich Site, and German Cancer Research Center, Heidelberg, Germany.
  • Ayuk F; Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.
  • Bachy E; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Salles G; German Cancer Consortium, Munich Site, and German Cancer Research Center, Heidelberg, Germany.
  • Jain MD; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • Subklewe M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
Blood ; 138(24): 2499-2513, 2021 12 16.
Article em En | MEDLINE | ID: mdl-34166502
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B / Antineoplásicos Imunológicos / Doenças Hematológicas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Receptores de Antígenos de Linfócitos T / Imunoterapia Adotiva / Linfoma Difuso de Grandes Células B / Antineoplásicos Imunológicos / Doenças Hematológicas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha